CompanyBristol-Myers Squibb Pharma EEIG
ATC codeL01XL08
EU authorised2022-04-04
· 4 yr ago
Flags
—
EMA EPAR
Evidence dossier ↗
Breyanzi CONFIRMED
lisocabtagene maraleucel · DLBCL
Current stage: 6 · first detected 2026-08-05
Also known as: breyanzi
Nordic decisions
| Country | Body | Verdict | Date | Source |
|---|---|---|---|---|
| Norge | Beslutningsforum | Innføres | 2026-04-27 | link |
Status timeline
| Date | Body | Status | Stage | Source |
|---|---|---|---|---|
| No status history. | ||||